홈CRL • NYSE
add
Charles River Lbrtrs ntrntl Inc
전일 종가
$177.87
일일 변동폭
$160.01 - $180.19
52주 변동폭
$91.86 - $230.02
시가총액
81.84억 USD
평균 거래량
101.80만
주가수익률
-
배당수익률
-
기본 거래소
NYSE
뉴스
재무
손익계산서
수익
순이익
| (USD) | 2025년 6월info | 전년대비 변동 |
|---|---|---|
수익 | 10.32억 | 0.59% |
운영비 | 2.12억 | 8.67% |
순이익 | 5232.60만 | -44.38% |
순이익률 | 5.07 | -44.71% |
주당 수익 | 3.12 | 11.43% |
EBITDA | 3.27억 | 26.18% |
유효 세율 | 26.22% | — |
대차대조표
총자산
총부채
| (USD) | 2025년 6월info | 전년대비 변동 |
|---|---|---|
현금 및 단기 투자 | 1.83억 | 2.01% |
총자산 | 75.61억 | -4.88% |
총부채 | 41.61억 | -0.34% |
총자기자본 | 34.00억 | — |
발행 주식 | 4921.42만 | — |
주가순자산비율 | 2.61 | — |
총자산이익률 | 5.68% | — |
자본이익률 | 6.93% | — |
현금 흐름
순현금흐름
| (USD) | 2025년 6월info | 전년대비 변동 |
|---|---|---|
순이익 | 5232.60만 | -44.38% |
영업 현금 흐름 | 2.05억 | 5.72% |
투자 현금 흐름 | -3733.90만 | 39.65% |
자금 조달 현금 흐름 | -2.27억 | 20.62% |
순현금흐름 | -4698.80만 | 70.17% |
잉여 현금 흐름 | 2.28억 | 54.82% |
정보
Charles River Laboratories International, Inc. is an American pharmaceutical and biotechnology contract research organisation headquartered in Wilmington, Massachusetts, United States. Founded in 1947, the company provides preclinical and clinical laboratory services for the development of new drugs, vaccines, and medical devices. Its operations span at least 20 countries, offering research models, safety assessment, and manufacturing support services to pharmaceutical, biotechnology, and government clients.
Charles River Laboratories is considered one of the largest CROs globally, known for its role in toxicology studies, animal research models, and microbial testing services used in regulatory submissions to health authorities such as the U.S. Food and Drug Administration. The company has also been the subject of public scrutiny and regulatory attention over its use of laboratory animals, including dogs, primates, and horseshoe crabs.
As of 2024, the company employs over 20,000 people worldwide and is publicly traded on the New York Stock Exchange under the ticker symbol CRL. Wikipedia
CEO
설립
1947
웹사이트
직원 수
19,400